Gastroenterology Research and Practice / 2012 / Article / Tab 1

Research Article

Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients

Table 1

Demographic and perioperative data on 34 patients treated with cytoreductive surgery and heated intraperitoneal chemotherapy with melphalan.

Gender
 Male14
 Female20
Age (mean)46.1
Primary diagnosis
 Appendix cancer23
 Mesothelioma6
 Colon cancer2
 Ovarian cancer2
 Urachal cancer1
Peritoneal cancer index (PCI)
 Mean21
 Range4–39
Completeness of cytoreduction score
 CC-121
 CC-27
 CC-36
Dose of melphalan
 50 mg/m25
 60 mg/m217
 70 mg/m210

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.